{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:34:57Z","timestamp":1790220897311,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004168","name":"Universit\u00e4t zu L\u00fcbeck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004168","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The association of hidradenitis suppurativa (HS) and asthma remains to be investigated. To assess the bidirectional association between HS and asthma. A population-based study was conducted to compare HS patients (<jats:italic>n<\/jats:italic>\u2009=\u20096779) with age-, sex-, and ethnicity-matched control subjects (<jats:italic>n<\/jats:italic>\u2009=\u200933,259) with regard to the incidence of new onset and the prevalence of preexisting asthma. Adjusted hazard ratios (HRs) and adjusted odds ratios (ORs) were calculated. The prevalence of preexisting asthma was higher in patients with HS relative to controls (9.6% vs. 6.9%, respectively; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The odds of HS were 1.4-fold greater in patients with a history of asthma (fully adjusted OR 1.41; 95% CI 1.27\u20131.55; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The incidence rate of new-onset asthma was estimated at 9.0 (95% CI 6.3\u201312.7) and 6.2 (95% CI 5.1\u20137.5) cases per 10,000 person-years among patients with HS and controls, respectively. The risk of asthma was not statistically different in patients with HS and controls (fully adjusted HR 1.53; 95% CI 0.98\u20132.38; <jats:italic>P\u2009<\/jats:italic>=\u20090.062). Relative to other patients with HS, those with HS and comorbid asthma were younger at the onset of HS (30.7 [14.7] vs. 33.3 [15.1], respectively; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and had a comparable risk of all-cause mortality (adjusted HR 0.86; 95% CI 0.44\u20131.68; <jats:italic>P<\/jats:italic>\u2009=\u20090.660). A history of asthma confers susceptibility to subsequent development of HS. This observation is of importance for clinicians managing both patients with HS and asthma. Further research is warranted to elucidate the pathomechanism underlying this finding.<\/jats:p>","DOI":"10.1007\/s00403-023-02693-4","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T12:01:56Z","timestamp":1693310516000},"page":"2845-2851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A history of asthma is associated with susceptibility to hidradenitis suppurativa: a population-based longitudinal study"],"prefix":"10.1007","volume":"315","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesal","family":"Shihade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Onn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Solomon-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"5","key":"2693_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","volume":"82","author":"SR Goldburg","year":"2020","unstructured":"Goldburg SR, Strober BE, Payette MJ (2020) Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 82(5):1045\u20131058. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.090","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2693_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","volume":"60","author":"A Alikhan","year":"2009","unstructured":"Alikhan A, Lynch PJ, Eisen DB (2009) Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 60(4):539\u2013561","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2693_CR3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/bjd.16101","volume":"178","author":"JR Ingram","year":"2018","unstructured":"Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V (2018) Population-based clinical practice research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol 178(4):917\u2013924. https:\/\/doi.org\/10.1111\/bjd.16101","journal-title":"Br J Dermatol"},{"key":"2693_CR4","doi-asserted-by":"publisher","unstructured":"Jemec GB, Kimball AB.Hidradenitis suppurativa: Epidemiology and scope of the problem.. J Am Acad Dermatol. 2015 Nov;73 (5 Suppl 1):S4\u20137. doi: https:\/\/doi.org\/10.1016\/j.jaad.2015.07.052.J Am Acad Dermatol. 2015. PMID: 26470614 Hidradenitis suppurativa: Epidemiology and scope of the problem.","DOI":"10.1016\/j.jaad.2015.07.052.J"},{"issue":"1","key":"2693_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/jdv.16677","volume":"35","author":"TV Nguyen","year":"2021","unstructured":"Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB (2021) Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 35(1):50\u201361. https:\/\/doi.org\/10.1111\/jdv.16677. (Epub 2020 Jul 16PMID: 3246037)","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1\u20133","key":"2693_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.EJPHAR.2011.08.047","volume":"672","author":"M Nazary","year":"2011","unstructured":"Nazary M, Van Der Zee HH, Prens EP, Folkerts G, Boer J (2011) Pathogenesis and pharmacotherapy of Hidradenitis suppurativa. Eur J Pharmacol 672(1\u20133):1\u20138. https:\/\/doi.org\/10.1016\/J.EJPHAR.2011.08.047","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2693_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/J.1365-2133.2006.07556.X","volume":"156","author":"EJ Giamarellos-Bourboulis","year":"2007","unstructured":"Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C et al (2007) Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 156(1):51\u201356. https:\/\/doi.org\/10.1111\/J.1365-2133.2006.07556.X","journal-title":"Br J Dermatol"},{"issue":"4","key":"2693_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/S13555-018-0264-Z","volume":"8","author":"AB Kimball","year":"2018","unstructured":"Kimball AB, Sundaram M, Gauthier G et al (2018) The comorbidity burden of Hidradenitis Suppurativa in the United States: a claims data analysis. Dermatol Ther (Heidelb) 8(4):557\u2013569. https:\/\/doi.org\/10.1007\/S13555-018-0264-Z","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"2693_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/J.JAAD.2020.12.051","volume":"85","author":"S Sherman","year":"2021","unstructured":"Sherman S, Kridin K, Bitan DT, Leshem YA, Hodak E, Cohen AD (2021) Hidradenitis suppurativa and atopic dermatitis: A 2-way association. J Am Acad Dermatol 85(6):1473\u20131479. https:\/\/doi.org\/10.1016\/J.JAAD.2020.12.051","journal-title":"J Am Acad Dermatol"},{"key":"2693_CR10","doi-asserted-by":"publisher","unstructured":"Frew JW, Hawkes JE, Krueger JG. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa [version 1; referees: 2 approved, 1 approved with reservations]. F1000Research. 2018 https:\/\/doi.org\/10.12688\/F1000RESEARCH.17267.1\/DOI","DOI":"10.12688\/F1000RESEARCH.17267.1\/DOI"},{"issue":"1","key":"2693_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/J.1600-065X.2011.01020.X","volume":"242","author":"PJ Barnes","year":"2011","unstructured":"Barnes PJ (2011) Pathophysiology of allergic inflammation. Immunol Rev 242(1):31\u201350. https:\/\/doi.org\/10.1111\/J.1600-065X.2011.01020.X","journal-title":"Immunol Rev"},{"issue":"5","key":"2693_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/BJD.14870","volume":"175","author":"JC Pascual","year":"2016","unstructured":"Pascual JC, Garc\u00eda-Mart\u00ednez FJ, Martorell A, Gonz\u00e1lez I, Hispan P (2016) Increased total serum IgE levels in moderate-to-severe hidradenitis suppurativa. Br J Dermatol 175(5):1101\u20131102. https:\/\/doi.org\/10.1111\/BJD.14870","journal-title":"Br J Dermatol"},{"issue":"5","key":"2693_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/S40257-017-0280-2","volume":"18","author":"ARJV Vossen","year":"2017","unstructured":"Vossen ARJV, Schoenmakers A, van Straalen KR, Prens EP, van der Zee HH (2017) Assessing pruritus in Hidradenitis Suppurativa: a cross-sectional study. Am J Clin Dermatol 18(5):687\u2013695. https:\/\/doi.org\/10.1007\/S40257-017-0280-2","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"2693_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1939-4551-7-12","volume":"7","author":"R Pawankar","year":"2014","unstructured":"Pawankar R (2014) Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organ J 7(1):12. https:\/\/doi.org\/10.1186\/1939-4551-7-12","journal-title":"World Allergy Organ J"},{"issue":"1","key":"2693_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/J.JAAD.2020.08.014","volume":"85","author":"SL Schell","year":"2021","unstructured":"Schell SL, Sun H, Maczuga S, Kirby JS, Nelson AM (2021) Cross-sectional study reveals reduced odds of allergies in people with hidradenitis suppurativa. J Am Acad Dermatol 85(1):232\u2013234. https:\/\/doi.org\/10.1016\/J.JAAD.2020.08.014","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"2693_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/ARCHDERMATOL.2010.328","volume":"146","author":"JL Hsiao","year":"2010","unstructured":"Hsiao JL, Antaya RJ, Berger T, Maurer T, Shinkai K, Leslie KS (2010) Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol 146(11):1265\u20131270. https:\/\/doi.org\/10.1001\/ARCHDERMATOL.2010.328","journal-title":"Arch Dermatol"},{"issue":"4","key":"2693_CR17","first-page":"1","volume":"149","author":"AD Cohen","year":"2010","unstructured":"Cohen AD, Dreiher J, Regev-Rosenberg S et al (2010) The quality indigators program in Clalit health services: the first decade. Harefuah. 149(4):1","journal-title":"Harefuah."},{"key":"2693_CR18","doi-asserted-by":"crossref","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis [Internet]. 1987;40 (5):373\u201383. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3558716","DOI":"10.1016\/0021-9681(87)90171-8"},{"issue":"5","key":"2693_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/PDE.14765","volume":"38","author":"JR Seivright","year":"2021","unstructured":"Seivright JR, Collier E, Grogan T, Hogeling M, Shi VY, Hsiao JL (2021) Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: a retrospective analysis. Pediatr Dermatol 38(5):1132\u20131136. https:\/\/doi.org\/10.1111\/PDE.14765","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"2693_CR20","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/JAMADERMATOL.2020.1281","volume":"156","author":"R Kj\u00e6rsgaard Andersen","year":"2020","unstructured":"Kj\u00e6rsgaard Andersen R, Jorgensen IF, Reguant R, Jemec GBE, Brunak S (2020) Disease trajectories for Hidradenitis Suppurativa in the Danish population. JAMA Dermatol 156(7):780\u2013786. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2020.1281","journal-title":"JAMA Dermatol"},{"key":"2693_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2013.00263","author":"M Kudo","year":"2013","unstructured":"Kudo M, Ishigatsubo Y, Aoki I (2013) Pathology of asthma. Front Microbiol. https:\/\/doi.org\/10.3389\/FMICB.2013.00263","journal-title":"Front Microbiol."},{"issue":"6","key":"2693_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/J.COI.2013.08.002","volume":"25","author":"DC Newcomb","year":"2013","unstructured":"Newcomb DC, Peebles RS (2013) Th17-mediated inflammation in asthma. Curr Opin Immunol 25(6):755\u2013760. https:\/\/doi.org\/10.1016\/J.COI.2013.08.002","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"2693_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/J.1398-9995.2011.02576.X","volume":"66","author":"L Cosmi","year":"2011","unstructured":"Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F (2011) Th17 cells: new players in asthma pathogenesis. Allergy 66(8):989\u2013998. https:\/\/doi.org\/10.1111\/J.1398-9995.2011.02576.X","journal-title":"Allergy"},{"issue":"1","key":"2693_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13223-020-00504-3\/FIGURES\/5","volume":"17","author":"Q Wei","year":"2021","unstructured":"Wei Q, Liao J, Jiang M, Liu J, Liang X, Nong G (2021) Relationship between Th17-mediated immunity and airway inflammation in childhood neutrophilic asthma. Allergy, Asthma Clin Immunol 17(1):1\u201312. https:\/\/doi.org\/10.1186\/S13223-020-00504-3\/FIGURES\/5","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"2693_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.139930","author":"JE Gudjonsson","year":"2020","unstructured":"Gudjonsson JE, Tsoi LC, Ma F et al (2020) Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis. JCI insight. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.139930","journal-title":"JCI insight"},{"issue":"9","key":"2693_CR26","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/J.JID.2021.02.742","volume":"141","author":"K Navrazhina","year":"2021","unstructured":"Navrazhina K, Garcet S, Gonzalez J, Grand D, Frew JW, Krueger JG (2021) In-Depth analysis of the Hidradenitis Suppurativa serum proteome identifies distinct inflammatory subtypes. J Invest Dermatol 141(9):2197\u20132207. https:\/\/doi.org\/10.1016\/J.JID.2021.02.742","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2693_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/BJD.14214","volume":"174","author":"AL Lima","year":"2016","unstructured":"Lima AL, Karl I, Giner T et al (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174(3):514\u2013521. https:\/\/doi.org\/10.1111\/BJD.14214","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02693-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02693-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02693-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:03:47Z","timestamp":1698649427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02693-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2693"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02693-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"ADC served as an advisor, investigator, or speaker for Abbvie, BI, Dexcel Pharma, Janssen, Novartis, Perrigo, Pfizer, and Rafa. None of the other authors have any conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}